mRNA antigen
mRNA antigen


Service introduction

mRNA has the potential to encode almost all proteins. mRNA vaccine technology can be used in antigen preparation to solve the difficulties in protein preparation: such as the long preparation cycle of traditional protein antigens, complex production process, and poor flexibility in production customization. As a platform technology, mRNA has the advantages of simple production process, short production cycle, and high flexibility. It can provide customers with antigen preparation faster and more cost-effectively, and conduct rapid target feasibility verification.


Service highlights

• mRNA has the potential to encode almost all proteins
• mRNA antigens have obvious advantages for difficult-to-prepare antigens such as transmembrane proteins, difficult-to-purify proteins, and poorly stable antigens
• mRNA antigen production process is simple
• mRNA antigen optimization is highly flexible
• mRNA antigen preparation cost is low


Service scope

• Preparation of mRNA antigens for immunization
• Preparation of mRNA antigens for target validation


Case sharing


mRNA antigen application case 1
mRNA immunization with multiple transmembrane antigens - Antigen A


  • Sequence design
  • Plasmid preparation
  • In vitro transcription
  • Translation level detection
  • mRNA-LNP preparation
  • Animal immunization
  • Sequence design
    Antigen A was codon optimized using multiple sequence design software.
  • Plasmid preparation
    Optimize and improve the supercoil ratio of plasmid
  • In vitro transcription
    Obtain high-purity mRNA stock solution
  • Translation level detection
    Translation level detection
  • mRNA-LNP preparation
    mRNA-LNP preparation
    Sample Particle size: nm PDI Encapsulation efficiency
    Antigen A mRNA-LNP 104.9 0.08 94.93%
  • Animal immunization
    Antigen A mRNA-LNP mouse immune serum titer results


mRNA antigen application case 2
mRNA immunization with multiple transmembrane antigens - Antigen B


  • Sequence design
  • Plasmid preparation
  • In vitro transcription
  • Translation level detection
  • mRNA-LNP preparation
  • Animal immunization
  • Sequence design
    Antigen B was codon optimized using multiple sequence design software.
  • Plasmid preparation
    Optimize and improve the supercoil ratio of plasmid
  • In vitro transcription
    Obtain high-purity mRNA stock solution
  • Translation level detection
    Translation level detection
  • mRNA-LNP preparation
    mRNA-LNP preparation
    Sample Particle size: nm PDI Encapsulation efficiency
    Antigen B mRNA-LNP 80.89 0.04 96.59%
  • Animal immunization
    Antigen B mRNA-LNP mouse immune serum titer results
    Antigen B mRNA-LNP alpaca immune serum titer results


Service process


Please contact on WhatsApp

Service Hotline: +86 400-808-5320

Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China

Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.

Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.

  • iso_copy_copy
  • iso_copy
  • iso
  • iso_copy_copy
  • iso_copy
  • iso
Contact Us

Service Hotline: +86 400-808-5320

Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China.

Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.

Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.

Copyright © Hzymes Biotechnology Co., Ltd. All Rights Reserved Web design

Site Map | Legal Notice | Privacy Policy |